Shandong Sito Bio-technology (300583) Stock Overview
Researches, develops, and produces steroid biomedicine intermediates. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 300583 from our risk checks.
300583 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Shandong Sito Bio-technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥17.24 |
| 52 Week High | CN¥31.63 |
| 52 Week Low | CN¥10.66 |
| Beta | 0.038 |
| 1 Month Change | -3.15% |
| 3 Month Change | -31.01% |
| 1 Year Change | 41.08% |
| 3 Year Change | 20.72% |
| 5 Year Change | -5.40% |
| Change since IPO | -52.46% |
Recent News & Updates
Recent updates
Revenues Not Telling The Story For Shandong Sito Bio-technology Co., Ltd. (SZSE:300583) After Shares Rise 28%
Feb 24
We Think Shandong Sito Bio-technology (SZSE:300583) Is Taking Some Risk With Its Debt
Dec 24There's Reason For Concern Over Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) Massive 26% Price Jump
Nov 15Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) 33% Share Price Surge Not Quite Adding Up
Sep 27Why We're Not Concerned Yet About Shandong Sito Bio-technology Co., Ltd.'s (SZSE:300583) 26% Share Price Plunge
Jun 06There May Be Reason For Hope In Shandong Sito Bio-technology's (SZSE:300583) Disappointing Earnings
May 05Risks Still Elevated At These Prices As Shandong Sito Bio-technology Co., Ltd. (SZSE:300583) Shares Dive 30%
Apr 16Shareholder Returns
| 300583 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 2.2% | 1.1% | 3.3% |
| 1Y | 41.1% | 20.0% | 20.7% |
Return vs Industry: 300583 exceeded the CN Pharmaceuticals industry which returned 20% over the past year.
Return vs Market: 300583 exceeded the CN Market which returned 20.7% over the past year.
Price Volatility
| 300583 volatility | |
|---|---|
| 300583 Average Weekly Movement | 7.5% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 9.8% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 300583 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300583's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 959 | Lianbiao Jin | www.sitobiotech.com |
Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9a-hydroxyandrost, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, ethylene deltenone, 16ß and 16a methyl epoxide, and hexahydro-3a-methyl, as well as androsta-1,4-diene-3,17-dione and estra-4,9-diene-3,17-dione. The company was founded in 2002 and is based in Heze City, China.
Shandong Sito Bio-technology Co., Ltd. Fundamentals Summary
| 300583 fundamental statistics | |
|---|---|
| Market cap | CN¥3.27b |
| Earnings (TTM) | -CN¥119.35m |
| Revenue (TTM) | CN¥986.06m |
Is 300583 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300583 income statement (TTM) | |
|---|---|
| Revenue | CN¥986.06m |
| Cost of Revenue | CN¥924.30m |
| Gross Profit | CN¥61.76m |
| Other Expenses | CN¥181.11m |
| Earnings | -CN¥119.35m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.63 |
| Gross Margin | 6.26% |
| Net Profit Margin | -12.10% |
| Debt/Equity Ratio | 41.6% |
How did 300583 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/30 01:28 |
| End of Day Share Price | 2025/06/30 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shandong Sito Bio-technology Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ban Wang | Minsheng Securities Co. |